INTRODUCTION: The most widely used test to identify undesired effects of drugs on the central and the peripheral nervous system is the neurobehavioural observation battery adapted from that first described by Irwin in mice. As a neurobehavioural assessment is based on observations; thus, all factors involved need to be controlled and standardised to make the data collected objective, reproducible, reliable and predictive of safety liabilities. METHODS: An observation battery comprising 58 signs with assigned full details of numerical scores was defined, and a standard design with associated recording, presenting and analysing data system was established. Validation studies were conducted with chlorpromazine, amphetamine, diazepam or clonidine given orally to rats or mice, in order to assess if this methodology could clearly differentiate the profile of effects produced by these compounds. The analysis of data from 80 control rats allowed for the assessment of the normal behaviour in order to characterise the inter-individual, daytime-related variability and the habituation of animals to the procedure. RESULTS: The reference compounds induced their typical and expected transient effects on neurobehaviour, observed both in the home cage and open-arena, and on body temperature. In particular, amphetamine induced a stimulation of the nervous system activities and marked hyperthermia. Chlorpromazine, diazepam and clonidine induced depressive, anxiolytic or sedative effects associated with hypothermia. The analysis of data collected in control animals allowed for the identification of 6 signs which scored differently from the assigned normality at the first handling occasion due to the characteristic fear reactions to the unknown, and 9 signs at 8 h post-dose due to the animal's habituation to experimental conditions and handling. DISCUSSION: The neurobehavioural changes expected by reference compounds administration were detected. These results confirm that by using this methodology the normal behaviour of the rat and the mouse, the daytime-related variability and the habituation of animals can be characterised, allowing a refined, reliable and reproducible neurobehavioural assessment of test substances in rodents.
INTRODUCTION: The most widely used test to identify undesired effects of drugs on the central and the peripheral nervous system is the neurobehavioural observation battery adapted from that first described by Irwin in mice. As a neurobehavioural assessment is based on observations; thus, all factors involved need to be controlled and standardised to make the data collected objective, reproducible, reliable and predictive of safety liabilities. METHODS: An observation battery comprising 58 signs with assigned full details of numerical scores was defined, and a standard design with associated recording, presenting and analysing data system was established. Validation studies were conducted with chlorpromazine, amphetamine, diazepam or clonidine given orally to rats or mice, in order to assess if this methodology could clearly differentiate the profile of effects produced by these compounds. The analysis of data from 80 control rats allowed for the assessment of the normal behaviour in order to characterise the inter-individual, daytime-related variability and the habituation of animals to the procedure. RESULTS: The reference compounds induced their typical and expected transient effects on neurobehaviour, observed both in the home cage and open-arena, and on body temperature. In particular, amphetamine induced a stimulation of the nervous system activities and marked hyperthermia. Chlorpromazine, diazepam and clonidine induced depressive, anxiolytic or sedative effects associated with hypothermia. The analysis of data collected in control animals allowed for the identification of 6 signs which scored differently from the assigned normality at the first handling occasion due to the characteristic fear reactions to the unknown, and 9 signs at 8 h post-dose due to the animal's habituation to experimental conditions and handling. DISCUSSION: The neurobehavioural changes expected by reference compounds administration were detected. These results confirm that by using this methodology the normal behaviour of the rat and the mouse, the daytime-related variability and the habituation of animals can be characterised, allowing a refined, reliable and reproducible neurobehavioural assessment of test substances in rodents.
Authors: Karsten Geletneky; Anne-Laure Leoni; Gabriele Pohlmeyer-Esch; Stephanie Loebhard; Barbara Leuchs; Constance Hoefer; Karin Jochims; Michael Dahm; Bernard Huber; Jean Rommelaere; Ottheinz Krebs; Jacek Hajda Journal: Comp Med Date: 2015-02 Impact factor: 0.982
Authors: Karsten Geletneky; Anne-Laure Leoni; Gabriele Pohlmeyer-Esch; Stephanie Loebhard; Andrea Baetz; Barbara Leuchs; Mandy Roscher; Constance Hoefer; Karin Jochims; Michael Dahm; Bernard Huber; Jean Rommelaere; Ottheinz Krebs; Jacek Hajda Journal: Comp Med Date: 2015-02 Impact factor: 0.982
Authors: Jean G Sathish; Siddhartha Bhatt; Jamie K DaSilva; Declan Flynn; Stephen Jenkinson; Amit S Kalgutkar; Maggie Liu; Balasubramanian Manickam; Jason Pinkstaff; William J Reagan; Norimitsu Shirai; Ahmed M Shoieb; Madhu Sirivelu; Saurabh Vispute; Allison Vitsky; Karen Walters; Todd A Wisialowski; Lawrence W Updyke Journal: Int J Toxicol Date: 2022-05-21 Impact factor: 2.380
Authors: Madeleine V King; Nisha Kurian; Si Qin; Nektaria Papadopoulou; Ben H C Westerink; Thomas I Cremers; Mark P Epping-Jordan; Emmanuel Le Poul; David E Ray; Kevin C F Fone; David A Kendall; Charles A Marsden; Tyson V Sharp Journal: Neuropsychopharmacology Date: 2013-08-28 Impact factor: 7.853
Authors: Christiane Gerke; Anna Maria Colucci; Carlo Giannelli; Silvia Sanzone; Claudia Giorgina Vitali; Luigi Sollai; Omar Rossi; Laura B Martin; Jochen Auerbach; Vito Di Cioccio; Allan Saul Journal: PLoS One Date: 2015-08-06 Impact factor: 3.240